haroon kalam
Broad Institute
Cambridge, MA, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Broad Institute
Cambridge, MA, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Central Drug Research Institute (CSIR)
Lucknow, India
Review Editor
Cancer Molecular Targets and Therapeutics
Danish Cancer Society Research Center (DCRC)
Copenhagen, Denmark
Review Editor
Cancer Molecular Targets and Therapeutics
Nanjing University of Chinese Medicine
Nanjing, China
Review Editor
Cancer Molecular Targets and Therapeutics
Texas Tech University Health Sciences Center
Lubbock, United States
Review Editor
Cancer Molecular Targets and Therapeutics
The University of Sheffield
Sheffield, United Kingdom
Review Editor
Cancer Molecular Targets and Therapeutics
Wroclaw Medical University
Wrocław, Poland
Review Editor
Cancer Molecular Targets and Therapeutics
University of Nebraska Medical Center
Omaha, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Wright State University
Dayton, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Barts and The London School of Medicine and Dentistry, Queen Mary University of London
London, United Kingdom
Review Editor
Cancer Molecular Targets and Therapeutics
University of Agriculture, Peshawar
Peshawar, Pakistan
Review Editor
Cancer Molecular Targets and Therapeutics
Seoul National University
Seoul, Republic of Korea
Review Editor
Cancer Molecular Targets and Therapeutics
University of Massachusetts Medical School
Worcester, United States
Review Editor
Cancer Molecular Targets and Therapeutics
School of Medicine, Indiana University Bloomington
Indianapolis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
College of Medicine, Seoul National University
Seoul, Republic of Korea
Review Editor
Cancer Molecular Targets and Therapeutics
Stanford University
Stanford, United States
Review Editor
Cancer Molecular Targets and Therapeutics